Up a level |
Drilon, A., Oxnard, G. R., Tan, D. S. W., Loong, H. H. F., Johnson, M., Gainor, J., McCoach, C. E., Gautschi, O., Besse, B., Cho, B. C., Peled, N., Weiss, J., Kim, Y. -J., Ohe, Y., Nishio, M., Park, K., Patel, J., Seto, T., Sakamoto, T., Rosen, E., Shah, M. H., Barlesi, F., Cassier, P. A., Bazhenova, L., De Braud, F., Garralda, E., Velcheti, V., Satouchi, M., Ohashi, K., Pennell, N. A., Reckamp, K. L., Dy, G. K., Wolf, J., Solomon, B., Falchook, G., Ebata, K., Nguyen, M., Nair, B., Zhu, E. Y., Yang, L., Huang, X., Olek, E., Rothenberg, S. M., Goto, K. and Subbiah, V. (2020). Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer. N. Engl. J. Med., 383 (9). S. 813 - 825. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406
Gordon, I. E., Rothman, L. S., Hargreaves, R. J., Hashemi, R., Karlovets, E., V, Skinner, F. M., Conway, E. K., Hill, C., Kochanov, R., V, Tan, Y., Wcislo, P., Finenko, A. A., Nelson, K., Bernath, P. F., Birk, M., Boudon, V, Campargue, A., Chance, K., V, Coustenis, A., Drouin, B. J., Flaud, J-M, Gamache, R. R., Hodges, J. T., Jacquemart, D., Mlawer, E. J., Nikitin, A., V, Perevalov, V., I, Rotger, M., Tennyson, J., Toon, G. C., Tran, H., Tyuterev, V. G., Adkins, E. M., Baker, A., Barbe, A., Cane, E., Csaszar, A. G., Dudaryonok, A., Egorov, O., Fleisher, A. J., Fleurbaey, H., Foltynowicz, A., Furtenbacher, T., Harrison, J. J., Hartmann, J-M, Horneman, V-M, Huang, X., Karman, T., Karns, J., Kassi, S., Kleiner, I, Kofman, V, Kwabia-Tchana, F., Lavrentieva, N. N., Lee, T. J., Long, D. A., Lukashevskaya, A. A., Lyulin, O. M., Makhnev, V. Yu, Matt, W., Massie, S. T., Melosso, M., Mikhailenko, S. N., Mondelain, D., Mueller, H. S. P., Naumenko, O., V, Perrin, A., Polyansky, O. L., Raddaoui, E., Raston, P. L., Reed, Z. D., Rey, M., Richard, C., Tobias, R., Sadiek, I, Schwenke, D. W., Starikova, E., Sung, K., Tamassia, F., Tashkun, S. A., Vander Auwera, J., Vasilenko, I. A., Vigasin, A. A., Villanueva, G. L., Vispoel, B., Wagner, G., Yachmenev, A. and Yurchenko, S. N. (2022). The HITRAN2020 molecular spectroscopic database. J. Quant. Spectrosc. Radiat. Transf., 277. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1879-1352
Goto, K., Oxnard, G., Tan, Shao-Weng D. S. W., Loong, Ho Fung H., Bauer, T. T., Gainor, J., McCoach, C., Gautschi, O., Besse, B., Cho, B. C., Peled, N., Weiss, J., Kim, Y., Ohe, Y., Horiike, A., Park, K., Huang, X., Olek, E., Subbiah, V, Drilon, A. and Wolf, J. (2021). Selpercatinib (LOXO-292) in patients with RET-Fusion+ non small-cell lung cancer (NSCLC). Pneumologie, 75. S. S42 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Wolf, J., Liu, S. V., Paz-Ares, L., Hu, J., Cho, B. C., Krzakowski, M., Chung, C. H., Patel, M., Taylor, M., Zeuner, H., Aziez, A., Huang, X., Osborne, S. and Farago, A. (2020). Entrectinib in NTRK fusion-positive sarcoma: integrated analysis of patients enrolled in STATRK-2, STARTRK-1 and ALKA-372-001. Oncol. Res. Treat., 43 (SUPPL 4). S. 34 - 35. BASEL: KARGER. ISSN 2296-5262